Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.31 Million CAD | 57.73% |
| 2022 | 834.21 Thousand CAD | 5.52% |
| 2021 | 790.57 Thousand CAD | -26.14% |
| 2020 | 1.07 Million CAD | -91.94% |
| 2019 | 13.28 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 115.17 Thousand CAD | -67.33% |
| 2024 Q2 | 179.64 Thousand CAD | 55.98% |
| 2023 Q2 | 609.01 Thousand CAD | 208.01% |
| 2023 Q4 | 352.51 Thousand CAD | 125.16% |
| 2023 FY | 1.31 Million CAD | 57.73% |
| 2023 Q1 | 197.72 Thousand CAD | 559.08% |
| 2023 Q3 | 156.56 Thousand CAD | -74.29% |
| 2022 Q3 | 905.41 Thousand CAD | 0.0% |
| 2022 FY | 834.21 Thousand CAD | 5.52% |
| 2022 Q4 | 30 Thousand CAD | -96.69% |
| 2021 FY | 790.57 Thousand CAD | -26.14% |
| 2020 FY | 1.07 Million CAD | -91.94% |
| 2019 FY | 13.28 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 98.484% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 73.244% |
| SQZ Biotechnologies Company | 85.61 Million USD | 98.463% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 95.548% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 96.468% |
| Mesoblast Limited | 5.9 Million USD | 77.706% |
| Propanc Biopharma, Inc. | 1.5 Million USD | 12.39% |
| Genus plc | 147.7 Million USD | 99.109% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 85.012% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | 1.918% |
| Marizyme, Inc. | 19.23 Million USD | 93.161% |
| ContraFect Corporation | 56.88 Million USD | 97.687% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 84.221% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 70.154% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | 11.018% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | 54.879% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | 52.844% |
| MultiCell Technologies, Inc. | 567.42 USD | -231795.245% |
| Accustem Sciences Inc. | 3.74 Million USD | 64.878% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 98.469% |
| EV Biologics, Inc. | 531.96 Thousand USD | -147.352% |
| Q BioMed Inc. | 3.43 Million USD | 61.712% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 94.676% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -237.766% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | 49.922% |
| Biomind Labs Inc. | 994.18 Thousand USD | -32.352% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 99.416% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 80.414% |
| Skye Bioscience, Inc. | 13.54 Million USD | 90.287% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | 35.773% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 5363.28% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 73.903% |
| IMV Inc. | 37.7 Million USD | 96.511% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 91.781% |
| Curative Biotechnology, Inc. | 1.83 Million USD | 28.297% |
| GB Sciences, Inc. | 1.42 Million USD | 7.37% |
| Alpha Cognition Inc. | 9.7 Million USD | 86.443% |
| HST Global, Inc. | 140.9 Thousand USD | -833.822% |
| CSL Limited | 3.44 Billion USD | 99.962% |
| Halberd Corporation | 74.84 Thousand USD | -1658.13% |
| Enzolytics Inc. | 2.17 Million USD | 39.628% |
| Resverlogix Corp. | 12.71 Million USD | 89.649% |
| Affymax, Inc. | 39.38 Million USD | 96.659% |
| SYBLEU INC | 160.87 Thousand USD | -717.909% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | 63.957% |
| argenx SE | 1.53 Billion USD | 99.914% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 97.709% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -26.036% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | 16.686% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | 61.356% |
| AVAX Technologies, Inc. | 7.31 Million USD | 82.0% |
| Zenith Capital Corp. | 8.94 Million USD | 85.287% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.841% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -7453.068% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | 46.409% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -667.202% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 98.675% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | 25.224% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | 33.276% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | 29.423% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 87.892% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | 31.5% |
| BioStem Technologies, Inc. | 22.97 Million USD | 94.273% |
| ONE Bio Corp. | 6.44 Million USD | 79.58% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -625.03% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | 1.469% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -16.971% |
| Agentix Corp. | 1.37 Million USD | 4.078% |
| LadRx Corporation | 3.81 Million USD | 65.48% |
| Cell Source, Inc. | 4.32 Million USD | 69.579% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -216.7% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -42.48% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -42.48% |
| NovAccess Global Inc. | 2.46 Million USD | 46.658% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | 45.287% |
| Itoco Inc. | 919.14 Thousand USD | -43.157% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 68.955% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -17.589% |
| Kadimastem Ltd | 2.41 Million USD | 45.404% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -402.747% |
| CytoDyn Inc. | 18.05 Million USD | 92.713% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -5127.939% |
| Mobile Lads Corp. | 554.54 Thousand USD | -137.279% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -497.888% |
| Qrons Inc. | 643.67 Thousand USD | -104.422% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | 7.323% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | 40.991% |
| Rebus Holdings, Inc. | 664 Thousand USD | -98.166% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | 27.556% |
| International Stem Cell Corporation | 5.27 Million USD | 75.037% |
| Bioxytran, Inc. | 3.82 Million USD | 65.556% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -2399.563% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -6368.171% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 96.372% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | 18.676% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -78.82% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | 57.704% |
| Neutra Corp. | 243.82 Thousand USD | -439.666% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 92.463% |
| PureTech Health plc | 144.59 Million USD | 99.09% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 93.578% |
| IXICO plc | 4.7 Million USD | 72.045% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 85.042% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 98.883% |
| CSL Limited | 3.89 Billion USD | 99.966% |
| Cellectis S.A. | 97.32 Million USD | 98.648% |